Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: Results of a pilot study [10]

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 193-195

  Tan, A C I T L ^a   Brouwer, J T ^b   Glue, P ^e   Van Leusen, R ^c   Kauffmann, R H ^d   Schalm, S W ^b   De Vries, R A ^c   Vroom, B ^b  

^a Academic Hospitals of Nijmegen   (United States)

^b Rijnsate Hospital Arnhem ^*

^c Schering Plough Research Institute   (Netherlands)

^d Leyenburg Hospital 's Gravenhage   (Netherlands)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ERYTHROPOIETIN; HEMOGLOBIN; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; FEVER; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MALE; MASS SPECTROMETRY; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETICULOCYTE;

EID: 0035160037     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.193     Document Type: Letter

References (5)

1. Combination of interferon alpha and ribavirin in the treatment of hepatitis C: Implications for the clinical nephrologist
2. The clinical pharmacology of ribavirin
3. Ribavirin and interferon alpha-2b in chronic hepatitis C: Assessment of possible pharmaco-kinetic and pharmacodynamic interactions
4. Interferon therapy for chronic hepatitis C in hemodialysis patients: Increased serum levels of interferon
5. 14C-ribavirin distribution and pharmacokinetic studies in rats, baboons and man